Press release
Investigation for Long-Term Investors in shares of Quest Diagnostics Incorporated (NYSE: DGX) announced
An investigation on behalf of investors in Quest Diagnostics Incorporated (NYSE: DGX) shares over potential wrongdoing.
Investors who purchased shares of Quest Diagnostics Incorporated (NYSE: DGX) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Quest Diagnostics directors breached their fiduciary duties and caused damage to the company and its shareholders.
Secaucus, NJ based Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. Quest Diagnostics Incorporated reported that its annual Total Revenue rose from over $9.43 billion in 2020 to over $10.78 billion in 2021 and that its Net Income increased from over $1.43 billion in 2020, to over $1.99 billion in 2021.
On January 1, 2022, New York Times released an article regarding the efficacy of Quest Diagnostics Incorporated and other screening labs for certain prenatal tests. The article states that these tests produce misleading results and do not correctly disclose the chances of a false positive. The article elaborates stating, "The test is advertised as getting positive microdeletion results right 75 percent of the time. But that figure comes from a single study that included nine confirmed cases of microdeletions, for a test that screens for seven such disorders. The company doesn't specify how the tests perform individually, and declined to provide that data. (In a statement, Quest said its test has "excellent performance.").
Shares of Quest Diagnostics Incorporated (NYSE: DGX) declined from $174.16 per share on December 31, 2021, to as low as $125.77 per share on February 24, 2022.
Those who purchased shares of Quest Diagnostics Incorporated (NYSE: DGX) have certain options and should contact the Shareholders Foundation.
Contact:
Christopher Clausen
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation for Long-Term Investors in shares of Quest Diagnostics Incorporated (NYSE: DGX) announced here
News-ID: 2619057 • Views: 531
More Releases from Shareholders Foundation
Investigation announced for Investors in Zynex, Inc. (NASDAQ: ZYXI) over potenti …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Zynex, Inc.
Investors who purchased shares of Zynex, Inc. (NASDAQ: ZYXI) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Zynex, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.
Englewood, CO based Zynex,…
Lawsuit filed for Investors in shares of Atlas Lithium Corporation (NASDAQ: ATLX …
An investor in shares of Atlas Lithium Corporation (NASDAQ: ATLX), filed a lawsuit against Atlas Lithium Corporation over alleged Securities Laws violations.
Investors who purchased shares of Atlas Lithium Corporation (NASDAQ: ATLX) have certain options and for certain investors are short and strict deadlines running. Deadline: August 1, 2023. NASDAQ: ATLX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Brazil based Atlas Lithium Corporation is a…
Investigation announced for Long-Term Investors in shares of Stanley Black & Dec …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Stanley Black & Decker, Inc.
Investors who are current long term investors in Stanley Black & Decker, Inc. (NYSE: SWK) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NYSE: SWK stocks follows a lawsuit…
Investigation announced for Investors who lost money with shares of DZS Inc. (NA …
An investigation was announced for investors of DZS Inc. (NASDAQ: DZSI) shares over potential securities laws violations by DZS Inc.
Investors who purchased shares of DZS Inc. (NASDAQ: DZSI), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of DZS Inc. (NASDAQ: DZSI) concerning whether a series…
More Releases for Quest
Quest Publishing Releases BCP Worksheets
Miami- Sept. 21, 2022 - As a community service in preparation for this hurricane season, the Inquesta Corporation, through its Quest Publishing division, has made its Business Continuity Planning (BCP) worksheets available free of charge for a limited time. Of course, windstorms are hardly the only hazards facing businesses, but these coming natural threats are a good reason for any organization to review its preparedness and security posture vis-à-vis all…
Creatinine Test Market 2018 Paramount Leading Players Quest Diagnostics, Quest D …
Creatinine Test Market Information: By Type (Urine, Blood), Device & Accessory (Clinical Analyzer, Creatinine Test Strips), Indication (Kidney Diseases, Kidney Infection, Kidney Failure, Urinary Tract Obstruction), End User - Global Forecast till 2023
The global creatinine test market is expected to grow at a CAGR of 4.5% during the forecast period.
KEY PLAYERS FOR CREATININE TESTS MARKET
Quest Diagnostics (U.S.), Merck (U.S.), Sonic Healthcare (Australia),…
QuEST Global Engineering appoints Ashok Baweja
Bangalore 24-Jan-2013: QuEST Global Engineering, a leading pure play engineering services provider with headquarters in Singapore, today announced the appointment of Mr. Ashok Baweja (Former Chairman HAL). In his new role, Mr Baweja will be responsible for the newly formed QuEST Global Defence Engineering Services, which will function as an independent company. The new company will focus…
Quest CE Introduces Course Builder
Quest CE, premier provider of insurance continuing education and FINRA firm element training, announced today the debut of its web-based course authoring software, Course Builder. As a value-added service to the Firm Element Suite, program administrators will have the ability to author, edit, and manage new courses and exams directly in Quest CE’s learning management system, Renaissance.
The interactive platform provides users with the capabilities to tailor their firm element…
Quest CE Presents: Quest CE's Correspondence CE Training
Quest CE, premier provider of insurance continuing education and FINRA firm element training, presents its Correspondence CE Training. Correspondence CE Training allows firms to condense an agent’s state required, multi-hour course into just one hour.
Wholesalers can choose from over 50 industry authored, Quest CE courses covering a variety of topics including annuity and ethics credit. Once the necessary course is selected, producers are supplied with a customizable self…
Introducing Quest CE’s Branch Audit Tool
MILWAUKEE – April 19, 2011 – Quest CE, premier provider of insurance continuing education and FINRA compliance training, is proud to announce the Branch Audit Tool, an innovative addition to their industry leading suite of Firm Element compliance training solutions. Fully integrated and accessible from Quest CE’s proprietary learning management system, Renaissance, the Branch Audit Tool is live and available for use.
Quest CE conducted surveys with compliance focus groups to…
